In NSCLC, ginsenoside Rg3 inhibits NF‐κB activation, which in turn reduces the expression of NF‐κB gene products and makes lung cancer cells sensitive to gamma radiation.110. The gene discussed is NFKB1; the disease is lung carcinoma.